首页> 外国专利> (20,22)-Dihydrocardenolide-glycosides as circulation aids - used in medicaments against coronary, cerebral and peripheral circulatory disorders

(20,22)-Dihydrocardenolide-glycosides as circulation aids - used in medicaments against coronary, cerebral and peripheral circulatory disorders

机译:(20,22)-二氢心烯内酯-糖苷作为循环助剂-用于抗冠状动脉,脑和外周循环障碍的药物

摘要

20.22-Dihydrocardenolide-glycosides are of general formula (I): (where R1, R3, R4 and R5 = H or hydroxyl; R2=(hydroxy)methyl or carbaldehyde; R6=H or opt. acylated hydroxy; Z=acovenose, arabinose, cymarose, oleandrose, rhamnose, thevetose, digitoxose, di-digitoxose, tri-digitoxose or tri-digitoxosemonoglucose; of which the OH-gps. are opt. substd. with alkyl or acyl; whereby two adjoining OH-gps. may be opt. substd. with alkylidene) The positive inotropic activity and thus the typical toxicity of (I) are strongly reduced when compared with the non-hydrogenated cardenolide-glycosides.
机译:20.22-二氢心烯内酯-糖苷具有通式(I):(其中R 1,R 3,R 4和R 5 = H或羟基; R 2 =(羟基)甲基或甲醛; R 6 = H或优选的酰化羟基; Z = aco糖,阿拉伯糖。 ,三聚葡萄糖,夹竹桃糖,鼠李糖,芥子糖,洋地黄糖,二洋地黄糖,三洋地黄糖或三洋地黄糖一葡萄糖;其中OH-gps被烷基或酰基取代;其中两个相邻的OH-gps可能被选择。与未氢化的烯醇内酯-糖苷相比,正性肌力活性降低,因此(I)的典型毒性被大大降低。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号